van Leeuwen's Response
In our paper, "Toxic Equivalency Factors (TEFs) for PCBs, PCDDs, PCDFs for Humans and Wildlife" (1), we described the results of a World Health Organization (WHO) working group that evaluated the existing TEFs for human risk assessment and derived consensus TEFs for fish and birds.
Starr et al. comment on the approach taken for the derivation of TEFs as described in our paper (1) and criticize the inadequate characterization of the uncertainty of the TEFs. They state that the following sentence is the only uncertainty characterization:
... it is unlikely for the use of this additive model to result in a great deal of error in predicting the concentrations of TCDD TEQs or responses at environmentally relevant levels due to nonadditive interactions.
In addition, they request explicit quantitative estimates on the uncertainty in each REP value, each TEF, and on the deviation from parallelism for the different end points.
Their first statement is incorrect. In the paper we clearly stated that the TEFs that were derived are "an order of magnitude estimate." This is a clear illustration of the overall uncertainty in TEF values based on the differences in outcomes of the different end points and the variation in available data for the different congeners. In addition, Starr et al. misinterpreted the sentence quoted above. This sentence is based on the opinion of Van It is important to note that a causal relationship between human exposure to Cr(VI) and increased lymphocyte DPC levels has not yet been established. In the only published study that measured DPC levels in circulating human lymphocytes after exposure to known doses of Cr(VI), we found that ingestion of water containing 10 ppm Cr(VI), which is 100 times the drinking water standard (0.10 ppm), did not yield an increase in DPC levels above predosing "background" levels (5). This is in spite of the fact that blood and urinary chromium levels demonstrated that a substantial fraction of ingested chromium had been absorbed [this study was not cited by Zhitkovich et al. (1) ]. Furthermore, in the only occupational DPC study where there was clear evidence of chromium exposure (chrome platers with highly elevated blood chromium levels), lymphocyte DPC levels were no greater than in the control group (6). In the other occupational and environmental Cr(VI) DPC studies (7-10), all of which reported increased DPC in the exposed population, chromium body burdens were measured in the exposed group only (8-J1), or were measured in both the exposed and control groups and found to be the same (2) . In short, no investigator has yet identified a chromium-exposed population that has shown both an increase in lymphocyte DPC levels and a chromium body burden relative to a contemporaneously sampled control group.
The animal data are also inconclusive. For example, lymphocyte DPC levels were not increased in rats fed 100-200 ppm Cr(VI) (1,000-2,000 times the drinking water standard), even though tissue chromium levels indicated that significant chromium absorption had occurred (11). The in vivo animal data that support a causal relationship reported a 2-to 4-fold increase in lymphocyte DPC in rats injected intraperitoneally (ip) with 40 mg/kg chromate (12), but even these results must be considered in light of the fact that another investigator using the same dosing regimen (but a different cell preparation technique) showed no increase in lymphocyte DPC (11). Accordingly, we believe that additional (and reproducible) in vivo animal exposure work should be performed before it can be concluded that relevant routes of Cr(VI) exposure can in fact cause elevated lymphocyte DPC in an intact organism.
As Zhitkovich et al. (1) indicated that their DPC analysis "has been validated using various cross-linking agents in cultured cells." Because we participated in the design and interpretation of the DPC interlaboratory validation study (4), we feel that some clarification is appropriate. The study, which involved five different laboratories testing many different metal compounds, demonstrated that while each lab obtained the same qualitative results regarding which metals induced DPC (copper, arsenic, and chromium) and those which did not (mercury, magnesium, permanganate, cadmium, lead, and aluminum), the actual degree of DPC measured in each lab was highly variable. For example, the increase in DPC induced by arsenic trioxide at 150 pm ranged from 8-to 60-fold. Although several possibilities for the interlaboratory variability were discussed, we believe that it may be premature to term the DPC assay as "validated"; we would encourage more research into the reproducibility of the method.
There are some apparent contradictions in the summary 
